Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 221

    1.

    Visceral adiposity and the risk of impaired glucose tolerance: a prospective study among Japanese Americans.

    Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):650-5.PMID: 12610016 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

    Boyko EJ, Fujimoto WY, Leonetti DL, Newell-Morris L.

    Diabetes Care. 2000 Apr;23(4):465-71.PMID: 10857936 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans.

    Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes. 2008 May;57(5):1269-75. Epub 2008 Feb 25.PMID: 18299316 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Visceral adiposity and the prevalence of hypertension in Japanese Americans.

    Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY.

    Circulation. 2003 Oct 7;108(14):1718-23. Epub 2003 Sep 15.PMID: 12975250 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

    Diabetes Care. 1998 Jan;21(1):76-9.PMID: 9538973 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans.

    Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, Fujimoto WY.

    Ann Intern Med. 2004 Jun 15;140(12):992-1000.PMID: 15197016 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.

    Nagaretani H, Nakamura T, Funahashi T, Kotani K, Miyanaga M, Tokunaga K, Takahashi M, Nishizawa H, Kishida K, Kuriyama H, Hotta K, Yamashita S, Matsuzawa Y.

    Diabetes Care. 2001 Dec;24(12):2127-33.PMID: 11723095 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.

    Chen KW, Boyko EJ, Bergstrom RW, Leonetti DL, Newell-Morris L, Wahl PW, Fujimoto WY.

    Diabetes Care. 1995 Jun;18(6):747-53.PMID: 7555498 [PubMed - indexed for MEDLINE]Related articles

    9.

    Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose.

    Liao D, Shofer JB, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2001 Jan;24(1):39-44.PMID: 11194238 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.

    Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y.

    Diabetes Care. 1997 Oct;20(10):1562-8.PMID: 9314636 [PubMed - indexed for MEDLINE]Related articles

    11.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic and adipose risk factors for NIDDM and coronary disease in third-generation Japanese-American men and women with impaired glucose tolerance.

    Fujimoto WY, Bergstrom RW, Leonetti DL, Newell-Morris LL, Shuman WP, Wahl PW.

    Diabetologia. 1994 May;37(5):524-32.PMID: 8056192 [PubMed - indexed for MEDLINE]Related articles

    13.

    Low insulin secretion and high fasting insulin and C-peptide levels predict increased visceral adiposity. 5-year follow-up among initially nondiabetic Japanese-American men.

    Boyko EJ, Leonetti DL, Bergstrom RW, Newell-Morris L, Fujimoto WY.

    Diabetes. 1996 Aug;45(8):1010-5.PMID: 8690145 [PubMed - indexed for MEDLINE]Related articles

    15.

    [The effects of body fat distribution on glucose tolerance in overweight subjects: glucose intolerance and insulin resistance induced by intra-abdominal fat accumulation]

    Yanagisawa K.

    Nippon Naibunpi Gakkai Zasshi. 1991 Nov 20;67(11):1240-51. Japanese. PMID: 1761138 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin, C-peptide, and leptin concentrations predict increased visceral adiposity at 5- and 10-year follow-ups in nondiabetic Japanese Americans.

    Tong J, Fujimoto WY, Kahn SE, Weigle DS, McNeely MJ, Leonetti DL, Shofer JB, Boyko EJ.

    Diabetes. 2005 Apr;54(4):985-90.PMID: 15793236 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans.

    McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY.

    Diabetes Care. 2003 Mar;26(3):758-63.PMID: 12610034 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance.

    Haffner SM, Miettinen H, Gaskill SP, Stern MP.

    Diabetologia. 1996 Oct;39(10):1201-7.PMID: 8897008 [PubMed - indexed for MEDLINE]Related articles

    19.

    Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.

    Ferrara CM, Goldberg AP.

    Diabetes Care. 2001 Feb;24(2):245-9.PMID: 11213873 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    A reduced-fat diet and aerobic exercise in Japanese Americans with impaired glucose tolerance decreases intra-abdominal fat and improves insulin sensitivity but not beta-cell function.

    Carr DB, Utzschneider KM, Boyko EJ, Asberry PJ, Hull RL, Kodama K, Callahan HS, Matthys CC, Leonetti DL, Schwartz RS, Kahn SE, Fujimoto WY.

    Diabetes. 2005 Feb;54(2):340-7.PMID: 15677490 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data